Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.3M Buy
37,900
+15,000
+66% +$1.78M 0.09% 219
2024
Q2
$2.84M Sell
22,900
-26,200
-53% -$3.37M 0.05% 293
2024
Q1
$6.48M Buy
49,100
+3,700
+8% +$456K 0.16% 134
2023
Q4
$4.95M Sell
45,400
-4,800
-10% -$498K 0.16% 138
2023
Q3
$5.17M Buy
50,200
+41,000
+446% +$4.42M 0.13% 134
2023
Q2
$1.06M Sell
9,200
-11,800
-56% -$1.34M 0.04% 249
2023
Q1
$2.23M Buy
+21,000
New +$2.27M 0.18% 102

Other funds holding MRK

Eisler Capital (US)'s MRK Position: Q3 2024 in Review

Eisler Capital (US) sold out of Merck (MRK) in Q3 2024, closing a stake of 8,107 shares — an estimated $963K sold.

Eisler Capital (US) first reported a position in MRK in Q2 2024 and held it in 1 quarter. The position peaked at $1M in Q2 2024. 3,492 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Eisler Capital (US) reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 8,107 Merck shares in Q3 2024, an estimated $963K.
  • Eisler Capital (US) first reported a position in Merck in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Merck position peaked at $1M in Q2 2024.
  • 3,492 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.